1 / 10

Bioimplants Market is estimated to reach $124,154 million by 2023, with a CAGR of 6.9% Forecast 2023

Bioimplants are surgically implanted to replace or support any damaged body organs to enhance function of any body organ. The major factors that drive the growth of the global bioimplants market include rise in prevalence of chronic diseases coupled with the rapidly aging population. Furthermore, increased awareness and technological advancements in bioimplant further propel the market growth. However, high implantation cost and lack of expertise are some of the factors restrict the market growth.

swati_tamhankar
Download Presentation

Bioimplants Market is estimated to reach $124,154 million by 2023, with a CAGR of 6.9% Forecast 2023

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Opportunity Analysis and Industry Forecast, 2016-2023 Bioimplants Market is estimated to reach $124,154 million by 2023, with a CAGR of 6.9% Forecast 2023 Global Opportunity Analysis and Industry Forecast, 2016-2023

  2. BIO-IMPLANTS MARKET  "Bioimplants Market by Type, and Material: Global Opportunity Analysis and Industry Forecast, 2017-2023," the market was valued at $77,738 million in 2016, and is estimated to reach $124,154 million by 2023, with a CAGR of 6.9% during the forecast period. Bioimplant are devices of human or animal origin used to replace a missing natural body structure, support an injured biological part, or improve an existing biological structure. The major factors that contribute to the market growth include increase in geriatric population, rapid technological advancements, rise in incidence of chronic diseases, surge in adoption of advanced treatment devices, and growth in awareness regarding both the disease and treatment devices available in the market. However, the stringent approval procedure of the bioimplant is expected to impede the market growth. In addition, significant unmet need in the emerging nations provides a lucrative opportunity for the market.

  3. BIO-IMPLANTS MARKET  High Incidence of Chronic Conditions with Increasing Age According to the National Institutes of Health report, it is estimated that 27% of the Japanese, 16% of the U.S., 24% of the UK, 17% of the Russian, and 14% of Chinese the population will be above 65 years of age by 2020. With age there is an increase in incidence of chronic diseases such as cardiovascular disease, neuropathic disorders, old age-related trauma, and osteoarthritis. For instance, according to the American Heart Association, in 2013 in the U.S., 70.2% of men and 70.9% of women in the range of age 60-79 years have cardiovascular disorders. Moreover, it is been predicted by World Health Organization that there will be an increase of 50% in cardiovascular disorders in China between 2010 and 2030 based on an increase in aging population. Download FREE Sample Copy Of this Report: https://www.alliedmarketresearch.com/request-sample/4652

  4. BIO-IMPLANTS MARKET  Bio-implants Market by Type 

  5. BIO-IMPLANTS MARKET  Bio-implants Market by Material 

  6. BIO-IMPLANTS MARKET  • Key Findings of the Bioimplants Market: • The cardiovascular bioimplant segment contributed for nearly one-fourth share of the global bioimplant market in 2016. • The spinal bioimplant segment is projected to grow at a significant CAGR from 2017 to 2023. • The natural biomaterial segment is projected to grow at a significant CAGR during the forecast period. • Germany and France are the major shareholders, which collectively accounted for more than one-third share of the Europe bioimplant market in 2016. • Japan is the major shareholder, accounting for more than one-third share of the Asia-Pacific bioimplant market in 2016.

  7. BIO-IMPLANTS MARKET  The North America market is projected to dominate the global bioimplant market in terms of revenue during the forecast period. This is majorly due to the increase in technological development and rise in incidence of cardiac, neuro, and spinal disorders. The Asia-Pacific market is expected to grow at the highest CAGR of 8.7% during the forecast period, owing to rise in awareness about the use of bio implants in the healthcare industry and surge in expenditures in emerging markets (such as India and China) to cater to the unmet medical needs. The major companies profiled in the report are Abbott Laboratories (St. Jude Medical, Inc.), Boston Scientific Corporation, Dentsply Sirona Inc., Johnson & Johnson (Ethicon, Inc.), Medtronic Plc, Smith & Nephew Plc, Stryker Corporation, Victrex Plc. (Invibio Ltd.), Wright Medical Group N.V., and Zimmer Biomet Holdings Inc. Purchase Complete Global Bio-Implants Market Research Report: https://www.alliedmarketresearch.com/purchase-enquiry/4652

  8. BIO-IMPLANTS MARKET Contact:Shriram Dighe5933 NE Win Sivers Drive#205, Portland, OR 97220United StatesToll Free: +1-800-792-5285UK: +44-845-528-1300Hong Kong: +852-301-84916India (Pune): +91-20-66346060Fax: +1⟨855⟩550-5975help@alliedmarketresearch.com Web: https://www.alliedmarketresearch.com

  9. BIO-IMPLANTS MARKET Thank You! For More Details Visit us at https://www.alliedmarketresearch.com Follow Us On

  10. BIO-IMPLANTS MARKET 

More Related